A Study to Assess Disease Activity and Adverse Events of Intravenous (IV) Telisotuzumab Vedotin Compared to IV Docetaxel in Adult Participants With Previously Treated Non-Squamous Non-Small Cell Lung Cancer (NSCLC)

NCT ID: NCT04928846

This clinical trial is studying a new treatment called telisotuzumab vedotin for adults with non-small cell lung cancer (NSCLC) who have already received treatment in the past. Researchers want to ...

Recruiting

Phase: PHASE3 Conditions: Non Small Cell Lung Cancer

Study of ALTO-300 in MDD

NCT ID: NCT05922878

This clinical trial is studying a new treatment called ALTO-300 for people with moderate to severe major depressive disorder (MDD). The goal is to find out how effective ALTO-300 is compared to a p...

Recruiting

Phase: PHASE2 Conditions: Major Depressive Disorder

A Study to Learn if a Combination of Fianlimab and Cemiplimab Versus Cemiplimab Alone is More Effective for Adult Participants With Advanced Non-Small Cell Lung Cancer (NSCLC)

NCT ID: NCT05785767

This clinical trial is studying whether a new combination of two medications, fianlimab and cemiplimab, is more effective for treating advanced non-small cell lung cancer (NSCLC) than cemiplimab al...

Recruiting

Phase: PHASE2 Conditions: Advanced Non-Small Cell Lung Cancer

A Trial to Learn How the Combination of Fianlimab With Cemiplimab and Chemotherapy Works Compared With Cemiplimab and Chemotherapy for Treating Adult Patients With Advanced Non-small Cell Lung Cancer

NCT ID: NCT05800015

This clinical trial is looking at a new treatment combination for adults with advanced non-small cell lung cancer (NSCLC), a type of lung cancer that has spread and is not able to be surgically rem...

Recruiting

Phase: PHASE2 Conditions: Non-small Cell Lung Cancer

Study to evaLuate the effIcacy and Safety of abeLacimab in High-risk Patients With Atrial Fibrillation Who Have Been Deemed Unsuitable for Oral antiCoagulation (LILAC-TIMI 76)

NCT ID: NCT05712200

The LILAC-TIMI 76 clinical trial is investigating the safety and effectiveness of a drug called abelacimab for patients with Atrial Fibrillation (AF) who are at high risk for blood clots but cannot...

Recruiting

Phase: PHASE3 Conditions: Atrial Fibrillation (AF)

A Study of Intismeran Autogene (V940) Plus Pembrolizumab (MK-3475) Versus Placebo Plus Pembrolizumab in Participants With Non-small Cell Lung Cancer (V940-002)

NCT ID: NCT06077760

This clinical trial is looking at a new treatment combination for patients with non-small cell lung cancer (NSCLC) who have had surgery to remove their cancer. The study compares the effects of a d...

Recruiting

Phase: PHASE3 Conditions: Non-small Cell Lung Cancer

A Study for GSK3862995B in Healthy Participants and Participants With Chronic Obstructive Pulmonary Disease

NCT ID: NCT06154837

This clinical trial is investigating a new medication called GSK3862995B to see if it is safe for healthy individuals and for people with Chronic Obstructive Pulmonary Disease (COPD). The main goal...

Recruiting

Phase: PHASE1 Conditions: Pulmonary Disease, Chronic Obstructive

A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease

NCT ID: NCT07064473

This clinical trial is studying whether a new medicine called vicadrostat, when taken together with an existing diabetes medicine called empagliflozin, can help lower the risk of heart problems in ...

Not yet recruiting

Phase: PHASE3 Conditions: Hypertension, Diabetes Mellitus, Type 2 +1 more

ALTO-100 in Bipolar Disorder With Depression (BD-D)

NCT ID: NCT06656416

This clinical trial, called ALTO-100, is investigating a new treatment for people with Bipolar Disorder I or II who are currently experiencing a major depressive episode. The goal is to see how eff...

Recruiting

Phase: PHASE2 Conditions: Bipolar Disorder I or II With a Major Depressive Episode

A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements

NCT ID: NCT03093116

This clinical trial is studying a new treatment called repotrectinib for patients with certain advanced solid tumors that have specific genetic changes known as ALK, ROS1, or NTRK rearrangements. T...

Recruiting

Phase: PHASE1 Conditions: Metastatic Solid Tumors, Locally Advanced Solid Tumors

Study of Ianalumab Versus Placebo in Addition to First-line Corticosteroids in Primary Immune Thrombocytopenia (ITP)

NCT ID: NCT05653349

This clinical trial is studying a medication called ianalumab to see how well it works in helping adults with a condition called primary immune thrombocytopenia (ITP) maintain a healthy platelet co...

Recruiting

Phase: PHASE3 Conditions: Primary Immune Thrombocytopenia (ITP)

Main Menu

Clinical Trials in Yuma, Arizona

11 Active Trials Found in Yuma

A Study to Assess Disease Activity and Adverse Events of Intravenous (IV) Telisotuzumab Vedotin Compared to IV Docetaxel in Adult Participants With Previously Treated Non-Squamous Non-Small Cell Lung Cancer (NSCLC)

Study of ALTO-300 in MDD

A Study to Learn if a Combination of Fianlimab and Cemiplimab Versus Cemiplimab Alone is More Effective for Adult Participants With Advanced Non-Small Cell Lung Cancer (NSCLC)

A Trial to Learn How the Combination of Fianlimab With Cemiplimab and Chemotherapy Works Compared With Cemiplimab and Chemotherapy for Treating Adult Patients With Advanced Non-small Cell Lung Cancer

Study to evaLuate the effIcacy and Safety of abeLacimab in High-risk Patients With Atrial Fibrillation Who Have Been Deemed Unsuitable for Oral antiCoagulation (LILAC-TIMI 76)

A Study of Intismeran Autogene (V940) Plus Pembrolizumab (MK-3475) Versus Placebo Plus Pembrolizumab in Participants With Non-small Cell Lung Cancer (V940-002)

A Study for GSK3862995B in Healthy Participants and Participants With Chronic Obstructive Pulmonary Disease

A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease

ALTO-100 in Bipolar Disorder With Depression (BD-D)

A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements

Study of Ianalumab Versus Placebo in Addition to First-line Corticosteroids in Primary Immune Thrombocytopenia (ITP)